In the News... Walmart's new insulin, Omnipod 5 studies, stem cell updates & more!
Diabetes Connections | Type 1 Diabetes
Release Date: 07/02/2021
Meet the newest insulin pump: all about “twiist” with Sequel CEO Alan Lotvin
Diabetes Connections | Type 1 Diabetes
This week, the newest pump coming to the market is called the twiist. It’s a very different shape – circular with a top half that twists off – with very different software – Tidepool Loop. The company behind this pump – they’re called Sequel - wants to be different as well, hoping to offer solutions to bigger issue than basal and bolus rates. It’s very ambitious and we have a wide ranging conversation about it all with Sequel’s CEO Alan Lotvin This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Our...
info_outline
In the News... Dexcom-to-watch update, Wegovy studies, night time hypo research and more!
Diabetes Connections | Type 1 Diabetes
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: Dexcom launches direct-to-watch with the G7 in the UK and Ireland, more studies looking at heart benefits with Wegovy and diabetes, a new T1D study investigating an injectable to prevent overnight hypoglycemia, lobbying for Levimir, a ChatGPT diabetes diagnosis and more! Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures Learn more about Drive The best way to keep up with Stacey and the show...
info_outline
The FDA took down this teen’s free bolus calculator. He needs your help to bring it back.
Diabetes Connections | Type 1 Diabetes
There used to be a lot of bolus calculators in the app store, maybe you’ve used one and haven’t updated it in a while. Don’t try now.. it’s likely been pulled. Apple and the FDA are cracking down on this types of tools – no unreasonable, right? But surely there are more coming.. how hard can it be to create a simple insulin bolus calculator that’s FDA approved, easy to find, easy to use, free, and doesn’t require you buy anything else? Turns out, it’s pretty darn hard. We’re talking about that today with the inventor of such an app with an interesting story – he’s still...
info_outline
Diabetes Technology: Expectation vs Reality with Dr. Stephen Ponder
Diabetes Connections | Type 1 Diabetes
Diabetes technology is getting better and better. We have automated insulin systems that link pumps and CGMs, and smart insulin pens that have precise calculations and reminders. It’s been quite the evolution over the past few years! But outcomes – time in range, A1Cs, aren’t exactly where experts thought they might be. I’m talking to Dr. Stephen Ponder about why that is, how a social media post he shared about this caused a strong reaction, and what does work for better long term outcomes. This podcast is not intended as medical advice. If you have those kinds of questions, please...
info_outline
In the News... diabetes drug pricing, vial shortage, pump using Tidepool Loop cleared, insulin cows and more!
Diabetes Connections | Type 1 Diabetes
It's In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: a new study shows that drugs like Ozempic can be produced for just a few dollars, we upate the insulin vial shortage Lilly announced, a new pump has been FDA cleared, a genetically modified cow can product human insulin, and more! Transcript and links below Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures Learn more about Drive The best way to keep up...
info_outline
Answering your questions about Tandem’s new Mobi pump (and more) with Director of Product Marketing Ben Mar
Diabetes Connections | Type 1 Diabetes
Approved last year, Tandem’s Mobi is now widely available. We’re getting an update from Ben Mar, Director of Product Marketing, on the features of the Mobi that make this tiny pump different and we look ahead to what Tandem is working on next. Ben also answers your questions about everything from algorithm updates, international access, and much more This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about ...
info_outline
"It needs to be easier" - DIY pioneer Dana Lewis turns her attention to exercise and T1D
Diabetes Connections | Type 1 Diabetes
This week, one of the pioneers of the DIY movement is turning her attention to exercise. Dana Lewis is partnering with other researchers to create a tool to help you make better and easier decisions around whatever workout you choose. There’s a lot of variability here – big difference between say, weight lifting and long distance running – so this is no easy task. Dana will explain the tools they’re using, the big goals here, and we get to catch up about what she’s using these days to manage her life with T1D which now includes ultramarathoning. This podcast is not intended as...
info_outline
In the News... ATTD updates, new CGMs, drops for diabetes eye disease, scholarships and more!
Diabetes Connections | Type 1 Diabetes
It's In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: The annual ATTD conference wraps up with news about CGMs, including new FDA approvals and a look at CGMs outside of the US, new eyedrops are being studied to treat diabetic eye disease and Beyond Type 1 opens applications for their annual Beyond Scholars. Transcript and links below Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures Learn more about Drive The best way to keep up with Stacey and...
info_outline
Behind the Wheel with T1D: Navigating Teen Driving and Diabetes
Diabetes Connections | Type 1 Diabetes
Let's talk about driving with diabetes! Getting a driver’s license as a teenager comes with enough challenges without type 1, but letting your child with T1D get behind the wheel is stressful, to say the least! I’m sharing what worked for us and expert advice that may help you and tips to let technology be your friend in the car. This is an excerpt of Stacey's book, "Still the World's Worst Diabetes Mom." It's the second book in her series. You can learn more about the books or on Learn more about that Stacey mentions here. This podcast is not intended as medical advice. If you have...
info_outline
Addressing the “shocking” lack of research into T1D & periods - Tidepool's Period Project
Diabetes Connections | Type 1 Diabetes
This week, addressing something that half of all people with diabetes experience but that there is woefully little information and study about. Why is there so little study about periods and type 1 diabetes? We’re talking to two organizations who are teaming up to change that – but they need your help. We’re talking about Tidepool's Period Project. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. You'll hear from Martina Rothenbühler, project leader data sciences and data protection officer at DCB, and Maya...
info_outlineCheck out Stacey's book: The World's Worst Diabetes Mom!
Join the Diabetes Connections Facebook Group!
Sign up for our newsletter here
-----
Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
-----
Get the App and listen to Diabetes Connections wherever you go!
Click here for iPhone Click here for Android
Transcription below:
Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of the past seven days. As always, I’m going to link up my sources in the Facebook comments – where we are live – and in the show notes at d-c dot com when this airs as a podcast.. so you can read more when you have the time.
XX
In the News is brought to you by Inside the Breakthrough. A new history of science podcast full of “Did You Know… Stuff”
XX
The top story this week - Walmart launches the first-ever and only private brand analog insulin at a discount off the list price.
This new brand ReliOn Novolog will have vials priced at $72 and a package of pens at $85 – compared to the list price of $289 and $558 respectively
Walmart worked directly with Novo Nordisk for the manufacturing of this insulin which will be in regular stores this week and in Sam's Club locations in mid-July.
Interestingly, this price is not below the one offered already by using coupons from groups like GoodRX or even the insulin manufacturers assistance programs. If you need help paying for your insulin, I’ll link up more info on that as well.
https://www.goodrx.com/novolog
XX
As expected, loads of info and studies from the ADA scientific sessions virtual conference that just wrapped up. Please check the links I’ll include because these are just highlights.
XX
Insulet is out with the results of their latest pivotal trial for the Omnipod 5 Automated Insulin Delivery System in very young children. The system improved time in range and reduced A1C in children 2 through just under six. I can tell you from experience, this is a tough age group for many reasons, including the fact that they can’t self-treat or really tell you what’s going on.
Parents and caregivers reported significantly improved sleep quality
Another Omipod 5 study with people aged 6 through 70 showed similar improvements. The system is awaiting FDA approval.
XX
ViaCyte, Inc. released preliminary clinical data from its stem cell-derived islet cell replacement therapy for people with type 1 diabetes. They show the implanted pancreatic cells produced their own insulin – which increase glucose-responsive C-peptide levels, increased time in range, and reduced A1C.
This method protects the stem cells in a pouch – that’s put very simply – Viactye is working on several different methods toward a functional cure.
https://www.prnewswire.com/news-releases/viacyte-reports-compelling-preliminary-clinical-data-from-islet-cell-replacement-therapy-for-patients-with-type-1-diabetes-301320084.html
XX
Another company on the same track.. Sernova Corp also showing their Cell Pouch transplanted with insulin-producing islets is safe and effective. One patient has finished the trial and has now remained insulin independent – that means no requirement for injectable insulin - for 14 months with optimal glucose control.
This is a person who’s lived with type 1 for 47 years..
https://www.thenewswire.com/press-releases/1k3wFKYMv-sernovas-principal-investigator-presents-interim-data-and-positive-patient-outcomes-of-phase-i-ii-t1d-study-at-the-american-diabetes-association-81st-scientific-sessions.html
XX
More from ADA conference - In two small studies, the ultra-rapid acting insulin Afrezza was found to be safe in children with type 1 and adults with type 2 diabetes.
Inhalable insulin is currently only approved for adults so the goal here was to look at safety.. which looks good. But it’s also worth noting that . Time in Range increased from 39% at baseline to 62% which is more than four additional hours spent in range each day!
https://diatribe.org/top-highlights-day-1-ada-scientific-sessions-2021
XX
New info in on Medtronic’s Extended-Wear Infusion Set. This is the pump inset that lasts seven days. This study shows that 75% of the time it makes it to the full seven days – Medtronic’s 3 day infusion sets have a 67% survival rate.
Device failure rates were very low – 8 cases out of more than 3-thousand sessions. Satisfaction was high – with people citing convenience of use, ease of insertion, and comfort of wear. This extended wear set is approved in Europe, available in Finland and has been submitted to the US FDA.
https://diatribe.org/day-2-3-highlights-ada-scientific-sessions-2021
XX
More to come, including news on Control IQ and an endurance athlete starts an amazing new trek.. but first, I want to tell you about one of our great sponsors who helps make Diabetes Connections possible.
- Inside the Breakthrough is a podcast that mixes historical wisdom with modern insight – it’s a science show that’s also entertaining. I love it. They cover everything from snake oil to the actual Eureka moment. There’s even an episode about the guy who discovered the importance of hand washing in hospitals and how no one believed him. And this all actually relates to diabetes! Listen to Inside the Breakthrough wherever you listen to podcasts..
Back to the news…
XX
Control-IQ continues to get high marks. This study looked at adults with an average age of 70 who already had A1Cs around 6.9. Three months after staring Control IQ, time in range increased from 64% to 87% which is 5 and a half hours more each day. All of these adults had prior experience with continuous glucose monitoring and insulin pumps.
XX
Former guest of the podcast, Sébastien Sasseville, is off on a mission to cycle across Canada in 14 days! Sasseville is a Canadian endurance athlete – he lives with type 1 - and it’s going to take about 250 miles a day to get to this goal.
Sasseville says he’s riding to bring attention to the issue of access to technology – he uses the tslim x2 and Dexcom G6 – and to support JDRF Canada’s Access for All campaign. He set off on June 28th and is documenting the journey on social media.
Sebastien Sasseville cycles across Canada: https://www.facebook.com/CanadaRuns.
That’s Diabetes Connections – In the News. If you like it, share it. And feel free to send me your news tips. Stacey @ diabetes dash connections dot com.
Please join me wherever you get podcasts for our next episode -Tuesday – a conversation with Dexcom’s CEO all about the upcoming G7.. I asked him all of your questions.
Our current episode out right now is with Nick Jonas – sharing his thoughts on the new campaign to educate about Time in Range and talking about he manages his T1D during concerts, shooting movies and during TV tapings.
Thanks and I’ll see you soon